Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the effectiveness and safety of Dysport for preventing episodic migraine in adults. The study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Episodic Migraine | Phase 3 | Status: ACTIVE_NOT_RECRUITING